The Clinical Trials Information System (CTIS) has been designated as a primary registry by the World Health Organisation (WHO) within the International Clinical Trials Registry Platform (ICTRP). Becoming a primary registry means CTIS adheres to specific criteria for content, data quality and validity, accessibility, unique identification, technical capacity, and administration. This ensures comprehensive research information is accessible to healthcare decision-makers globally.
CTIS has already been a registered data provider for WHO since May 2023. Designation as a primary registry represents a significant milestone in facilitating data sharing and promoting transparency and trust in clinical research…
